| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy
|
Ostrominski, John W.
|
|
|
11 |
7 |
p. 735-748
|
artikel
|
| 2 |
Correction
|
|
|
|
11 |
7 |
p. 864
|
artikel
|
| 3 |
Differentiation Between Worsening Heart Failure and Decompensated Heart Failure
|
Bozkurt, Biykem
|
|
|
11 |
7 |
p. 859-861
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
11 |
7 |
p. vi-x
|
artikel
|
| 5 |
Effective and Cost-Conscious Utilization of SGLT2 Inhibitors
|
Li, Song
|
|
|
11 |
7 |
p. 836-837
|
artikel
|
| 6 |
Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
|
Khan, Muhammad Shahzeb
|
|
|
11 |
7 |
p. 825-835
|
artikel
|
| 7 |
Full issue PDF
|
|
|
|
11 |
7 |
p. I-CXLVIII
|
artikel
|
| 8 |
General Information
|
|
|
|
11 |
7 |
p. xi-xii
|
artikel
|
| 9 |
Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation
|
Cox, Zachary L.
|
|
|
11 |
7 |
p. 791-805
|
artikel
|
| 10 |
Gut Microbiome in Cardiovascular Disease and Heart Failure
|
Mamic, Petra
|
|
|
11 |
7 |
p. 822-824
|
artikel
|
| 11 |
Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan
|
Mohebi, Reza
|
|
|
11 |
7 |
p. 855-858
|
artikel
|
| 12 |
Instructions for Authors
|
|
|
|
11 |
7 |
p. xiii-xxiii
|
artikel
|
| 13 |
Istaroxime in HFpEF
|
Tedford, Ryan J.
|
|
|
11 |
7 |
p. 772-774
|
artikel
|
| 14 |
Ketogenic Diet in Heart Failure
|
Kodur, Nandan
|
|
|
11 |
7 |
p. 838-844
|
artikel
|
| 15 |
Management of Heart Failure–Related Cardiogenic Shock
|
Narang, Nikhil
|
|
|
11 |
7 |
p. 845-851
|
artikel
|
| 16 |
Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality
|
Molinaro, Antonio
|
|
|
11 |
7 |
p. 810-821
|
artikel
|
| 17 |
Myeloperoxidase in Heart Failure With Preserved Ejection Fraction
|
de Boer, Rudolf A.
|
|
|
11 |
7 |
p. 788-790
|
artikel
|
| 18 |
Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF
|
Michaëlsson, Erik
|
|
|
11 |
7 |
p. 775-787
|
artikel
|
| 19 |
Natural Language Processing for Adjudication of Heart Failure in the Electronic Health Record
|
Cunningham, Jonathan W.
|
|
|
11 |
7 |
p. 852-854
|
artikel
|
| 20 |
Optimizing Background Therapy for Heart Failure in Clinical Trials
|
Desai, Akshay S.
|
|
|
11 |
7 |
p. 806-809
|
artikel
|
| 21 |
Prevalent and Incident Anemia in PARADIGM-HF and the Effect of Sacubitril/Valsartan
|
Curtain, James P.
|
|
|
11 |
7 |
p. 749-759
|
artikel
|
| 22 |
Reply
|
Schrage, Benedikt
|
|
|
11 |
7 |
p. 863
|
artikel
|
| 23 |
SERCA2a Agonist Effects on Cardiac Performance During Exercise in Heart Failure With Preserved Ejection Fraction
|
Sarma, Satyam
|
|
|
11 |
7 |
p. 760-771
|
artikel
|
| 24 |
Upper Body Hypoxemia During ECMELLA
|
Pollari, Francesco
|
|
|
11 |
7 |
p. 862
|
artikel
|
Tijdschrift beschrijving